Literature DB >> 19494594

Different aspects of peritoneal damage: fibrosis and sclerosis.

Guido Garosi.   

Abstract

Peritoneal sclerosis is very common in peritoneal dialysis patients. It can vary from the mild, clinically silent simple sclerosis always present after years of peritoneal dialysis, to rare but dramatic and often fatal cases of encapsulating peritoneal sclerosis. Their frequency, pathology, animal models, pathogenesis, clinical manifestations, therapy, and prevention are reviewed. Peritoneal fibrosis and sclerosis is a complex phenomenon. At one end of the spectrum we have simple sclerosis: the mild, clinically silent sclerosis always present after years of peritoneal dialysis. At the other end, we have encapsulating peritoneal sclerosis, which is rare but dramatic and fatal.

Entities:  

Mesh:

Year:  2009        PMID: 19494594     DOI: 10.1159/000223779

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  7 in total

Review 1.  Encapsulating peritoneal sclerosis in children.

Authors:  Constantinos J Stefanidis; Rukshana Shroff
Journal:  Pediatr Nephrol       Date:  2013-11-21       Impact factor: 3.714

Review 2.  Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey.

Authors:  M Graversen; S Detlefsen; P Pfeiffer; L Lundell; M B Mortensen
Journal:  Clin Exp Metastasis       Date:  2018-04-28       Impact factor: 5.150

3.  Abatacept as a therapeutic option in the treatment of encapsulated peritoneal sclerosis: an experimental rat model.

Authors:  Latife Bircan; Suleyman Karakose; Hatice Unverdi; Ayşe Zeynep Bal; Selman Unverdi; Murat Duranay
Journal:  Int Urol Nephrol       Date:  2017-02-11       Impact factor: 2.370

4.  No need for an "expiry date" in chronic peritoneal dialysis to prevent encapsulating peritoneal sclerosis.

Authors:  Guido Garosi; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2009-12       Impact factor: 2.370

Review 5.  Encapsulating peritoneal sclerosis: the state of affairs.

Authors:  Mario R Korte; Denise E Sampimon; Michiel G H Betjes; Raymond T Krediet
Journal:  Nat Rev Nephrol       Date:  2011-08-02       Impact factor: 28.314

6.  Beta-catenin participates in dialysate-induced peritoneal fibrosis via enhanced peritoneal cell epithelial-to-mesenchymal transition.

Authors:  Shuiyu Ji; Hao Deng; Wei Jin; Pengpeng Yan; Rending Wang; Lisha Pang; Jingyi Zhou; Jiaming Zhang; Xiaoying Chen; Xiang Zhao; Jia Shen
Journal:  FEBS Open Bio       Date:  2017-01-19       Impact factor: 2.693

Review 7.  Mesenchymal Conversion of Mesothelial Cells Is a Key Event in the Pathophysiology of the Peritoneum during Peritoneal Dialysis.

Authors:  Manuel López-Cabrera
Journal:  Adv Med       Date:  2014-01-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.